Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Clinical trial NCT06920316 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06920316
Sponsor: St. George's Hospital, London
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease

Start date: 2025-05-01
Primary completion: 2027-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.